Literature DB >> 126383

Increased breakdown of glycosaminoglycans and appearance of corrective enzyme after skin transplants in Hunter syndrome.

M F Dean, H Muir, P F Benson, L R Button, J R Batchelor, M Bewick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 126383     DOI: 10.1038/257609a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

Review 1.  Replacement therapy in the mucopolysaccharidoses.

Authors:  M F Dean
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1978

2.  Spring Meeting, Guy's Hospital, London 26 and 27 March 1976.

Authors: 
Journal:  Arch Dis Child       Date:  1976-09       Impact factor: 3.791

3.  Enzyme replacement therapy by fibroblast transplantation: long-term biochemical study in three cases of Hunter's syndrome.

Authors:  M F Dean; R L Stevens; H Muir; P F Benson; L R Button; R L Anderson; A Boylston; J Mowbray
Journal:  J Clin Invest       Date:  1979-01       Impact factor: 14.808

4.  A clinical trial of fibroblast transplantation for the treatment of mucopolysaccharidoses.

Authors:  D A Gibbs; E Spellacy; R Tompkins; R W Watts; J F Mowbray
Journal:  J Inherit Metab Dis       Date:  1983       Impact factor: 4.982

5.  Long-term production and delivery of human growth hormone in vivo.

Authors:  M W Heartlein; V A Roman; J L Jiang; J W Sellers; A M Zuliani; D A Treco; R F Selden
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

6.  Attempted enzyme replacement using human amnion membrane implantations in mucopolysaccharidoses.

Authors:  J Muenzer; E F Neufeld; G Constantopoulos; R C Caruso; M I Kaiser-Kupfer; A Pikus; J Danoff; R R Berry; H D McDonald; J N Thompson
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

7.  Intravenous administration of phosphorylated acid alpha-glucosidase leads to uptake of enzyme in heart and skeletal muscle of mice.

Authors:  A T Van der Ploeg; M A Kroos; R Willemsen; N H Brons; A J Reuser
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.